Company Filing History:
Years Active: 1976-1979
Title: An Insight into the Innovations of James Winslow Bastian
Introduction
James Winslow Bastian is an innovative inventor based in Park Forest, Illinois. With a total of two patents to his name, Bastian has made noteworthy contributions to the field of pharmaceuticals, particularly in the treatment of conditions related to gastric acid secretion and vasoconstrictive therapy.
Latest Patents
Bastian's latest patents include a unique method for suppressing gastric acid secretion through the oral administration of calcitonin. This method aims to effectively address gastric or duodenal ulcers and similar conditions by reducing gastric acidity in mammalian hosts, including humans. Furthermore, Bastian has developed pharmaceutical preparations and related methods that utilize guanidine compounds to provide therapeutic solutions for conditions necessitating vasoconstrictive therapy. These preparations involve a pharmaceutically acceptable carrier combined with a guanidine compound, showcasing his inventive prowess in the pharmaceutical domain.
Career Highlights
Bastian is associated with Armour Pharmaceutical Company, where he continues to push the boundaries of medical science through his inventions. His dedication and innovative spirit have positioned him as a significant contributor in the pharmaceutical industry, focusing on developing treatments that enhance patient care and address critical health concerns.
Collaborations
Throughout his career, James Winslow Bastian has had the opportunity to collaborate with talented coworkers such as John Lawrence Hughes and Robert Chung-Huan Liu. These partnerships reflect a collaborative approach to innovation, fostering an environment where creative ideas can thrive and lead to meaningful advancements in medicine.
Conclusion
James Winslow Bastian's work exemplifies the impact of innovation in the pharmaceutical sector. With his patents addressing vital health issues, he has significantly contributed to improving treatment methodologies. As he continues his work at Armour Pharmaceutical Company, his inventive contributions will likely pave the way for further advancements in medical therapeutics.